Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-14

Clinical Trial Update: Nutritional Therapy in Late-onset Pompe Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nutritional therapy for late-onset Pompe disease with muscle loss; current status is unknown according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McMaster University | Conditions: Pompe Disease, Muscle Loss | Phase 2 | Status: UNKNOWN